--- title: China Insights description: China insights and practical advice for global technology companies looking to do business in China's ever-changing market. --- [Skip to content](https://www.adgchina.co/china-insights#main-content) [![ADGLogo-1](https://www.adgchina.co/hs-fs/hubfs/ADGLogo-1.png?width=168&height=85&name=ADGLogo-1.png)](https://adgchina.co) - Solutions Show submenu for Solutions - [China Growth Platform](https://www.adgchina.co/adg_growth_platform) - [Partnership Development](https://www.adgchina.co/en/technology-partnerships) - [China Advisory & Local Solutions](https://www.adgchina.co/china-market-services) - Network Show submenu for Network - [Partners](https://www.adgchina.co/ecosystem) - [China Insights](https://www.adgchina.co/china-insights) - [中文](https://china.adgchina.co/) Open main navigation Close main navigation - Solutions Show submenu for Solutions - [China Growth Platform](https://www.adgchina.co/adg_growth_platform) - [Partnership Development](https://www.adgchina.co/en/technology-partnerships) - [China Advisory & Local Solutions](https://www.adgchina.co/china-market-services) - Network Show submenu for Network - [Partners](https://www.adgchina.co/ecosystem) - [China Insights](https://www.adgchina.co/china-insights) - [中文](https://china.adgchina.co/) Let's Talk [![China orphan drug regulations, magnifying glass over map of China, orphan drug vial, Shanghai skyline](https://www.adgchina.co/hubfs/china-orphan-drug-regulatory-reform-hero-final.jpeg)](https://www.adgchina.co/china-insights/chinas-new-exclusivity-rules-are-rewriting-orphan-drug-strategy) ### [China's New Exclusivity Rules Are Rewriting Orphan Drug Strategy](https://www.adgchina.co/china-insights/chinas-new-exclusivity-rules-are-rewriting-orphan-drug-strategy) [Life Sciences](https://www.adgchina.co/china-insights/tag/life-sciences)[Market Entry](https://www.adgchina.co/china-insights/tag/market-entry)[China Biopharma](https://www.adgchina.co/china-insights/tag/china-biopharma)[Orphan Drugs](https://www.adgchina.co/china-insights/tag/orphan-drugs)[Clinical Development](https://www.adgchina.co/china-insights/tag/clinical-development)[Rare Disease](https://www.adgchina.co/china-insights/tag/rare-disease)[NMPA](https://www.adgchina.co/china-insights/tag/nmpa)[Regulatory Reform](https://www.adgchina.co/china-insights/tag/regulatory-reform) Aug 5, 2026 Global pharma has treated China as a secondary market for rare disease drugs for a simple reason: th... [![Researcher examining CHO cell culture flasks in a modern Chinese biopharmaceutical manufacturing facility](https://www.adgchina.co/hubfs/cho-cells-china-biologics-hero-1.png)](https://www.adgchina.co/china-insights/how-chinese-hamster-ovary-cells-took-over-modern-medicine) ### [How Chinese Hamster Ovary Cells Took Over Modern Medicine (and why it impacts global life sciences software)](https://www.adgchina.co/china-insights/how-chinese-hamster-ovary-cells-took-over-modern-medicine) [Biologics](https://www.adgchina.co/china-insights/tag/biologics)[CHO Cells](https://www.adgchina.co/china-insights/tag/cho-cells)[WuXi Biologics](https://www.adgchina.co/china-insights/tag/wuxi-biologics)[Market Entry](https://www.adgchina.co/china-insights/tag/market-entry)[Drug Development](https://www.adgchina.co/china-insights/tag/drug-development)[China Biopharma](https://www.adgchina.co/china-insights/tag/china-biopharma)[CDMO](https://www.adgchina.co/china-insights/tag/cdmo)[Biologics Manufacturing](https://www.adgchina.co/china-insights/tag/biologics-manufacturing) Jul 1, 2026 You have probably never heard of CHO cells unless you work in biologics or global drug manufacturing... [![Scientist reviewing molecular data on screens in a modern Chinese pharmaceutical research laboratory](https://www.adgchina.co/hubfs/china-adc-market-software-demand-hero.png)](https://www.adgchina.co/china-insights/selling-software-into-chinas-booming-antibody-drug-conjugate-development-market) ### [Selling Software into China's Booming Antibody-Drug Conjugate Development Market](https://www.adgchina.co/china-insights/selling-software-into-chinas-booming-antibody-drug-conjugate-development-market) [Insights](https://www.adgchina.co/china-insights/tag/insights)[Life Sciences](https://www.adgchina.co/china-insights/tag/life-sciences)[CRO](https://www.adgchina.co/china-insights/tag/cro)[Growth](https://www.adgchina.co/china-insights/tag/growth)[ADC](https://www.adgchina.co/china-insights/tag/adc) Jun 1, 2026 [![](https://www.adgchina.co/hubfs/ChatGPT%20Image%20Feb%2020%2c%202026%2c%2009_42_23%20PM.png)](https://www.adgchina.co/china-insights/chinas-biotech-inflection-point-from-fast-follower-to-strategic-force) ### [China’s Biotech Inflection Point: Fast Follower to Strategic Force](https://www.adgchina.co/china-insights/chinas-biotech-inflection-point-from-fast-follower-to-strategic-force) [Insights](https://www.adgchina.co/china-insights/tag/insights)[Life Sciences](https://www.adgchina.co/china-insights/tag/life-sciences) Apr 15, 2025 Over the past two decades, China’s life sciences system has undergone a structural transformation th... [![Say goodbye to China the smart way](https://www.adgchina.co/hubfs/chinaby.png)](https://www.adgchina.co/china-insights/exit_china_smartly) ### [The smart way to reduce your exposure to China](https://www.adgchina.co/china-insights/exit_china_smartly) [Insights](https://www.adgchina.co/china-insights/tag/insights)[SaaS / Cloud](https://www.adgchina.co/china-insights/tag/saas-cloud) Jun 4, 2024 How to exit China without upsetting existing customers or losing valuable revenues [![](https://www.adgchina.co/hubfs/istockphoto-1141912980-612x612.jpg)](https://www.adgchina.co/china-insights/how-software-companies-really-enter-china) ### [How Global Software Companies Enter China](https://www.adgchina.co/china-insights/how-software-companies-really-enter-china) [Insights](https://www.adgchina.co/china-insights/tag/insights)[SaaS / Cloud](https://www.adgchina.co/china-insights/tag/saas-cloud)[Life Sciences](https://www.adgchina.co/china-insights/tag/life-sciences)[Growth](https://www.adgchina.co/china-insights/tag/growth) Mar 25, 2024 A guide to the most common models software companies use to enter China In the rapidly evolving glob... [1](https://www.adgchina.co/china-insights) [2](https://www.adgchina.co/china-insights/page/2) [3](https://www.adgchina.co/china-insights/page/3) [4](https://www.adgchina.co/china-insights/page/4) [5](https://www.adgchina.co/china-insights/page/5) [Next](https://www.adgchina.co/china-insights/page/2) [Last](https://www.adgchina.co/china-insights/page/8) © 2026 ADG China - Solutions - [China Growth Platform](https://www.adgchina.co/adg_growth_platform) - [Partnership Development](https://www.adgchina.co/en/technology-partnerships) - [China Advisory & Local Solutions](https://www.adgchina.co/china-market-services) - Network - [Partners](https://www.adgchina.co/ecosystem) - [China Insights](https://www.adgchina.co/china-insights) - [中文](https://china.adgchina.co/) --- [Find us on LinkedIn](https://www.linkedin.com/company/3206920) © 2026 ADG China